Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2003
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2467854A1 Sir2 products and activities
06/05/2003CA2466881A1 Cell culture process
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466627A1 Chromatographic purification of recombinant human erythropoietin
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2466298A1 Methods of increasing protein expression levels
06/04/2003EP1316617A1 Methods of synthesizing cell-free protein
06/04/2003EP1316616A1 Method for producing linear DNA fragments for the in vitro expression of proteins
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1315974A2 Split-ubiquitin based reporter systems and methods of their use
06/04/2003EP1315826A1 Enhanced in vitro synthesis of active proteins containing disulfide bonds
06/04/2003EP1315822A2 Modified construct downstream of the initiation codon for recombinant protein overexpression
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315810A2 Family member of inhibitor of apoptosis proteins
06/04/2003EP1315803A2 Enzymes having high temperature polymerase activity and methods of use thereof
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315753A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315522A2 Calycins
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315516A2 Modulation of beta-amyloid levels by beta-secretase bace2
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1151299A4 Method of site specific labeling of proteins and uses therefor
06/04/2003EP0716695B1 Human calcium channel compositions and methods using them
06/04/2003EP0692028B1 Pharmaceuticals based on papillomaviruses
06/04/2003EP0670730B1 Fusion protein comprising two tumor necrosis factor receptors
06/04/2003EP0658201B1 Dna sequences involved in soraphen biosynthesis by myxobacteria
06/04/2003EP0656007B1 Delta opioid receptor genes
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422281A G-protein coupled receptors
06/04/2003CN1422280A Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same
06/04/2003CN1421531A Prepn process of humanized monoclonal antibody resisting hepatitis B virus surface antigen
06/04/2003CN1421461A Fusion protein with reinforced erythrocytin activity in vivo
06/04/2003CN1421457A New human protein with cancer cell growth inhibiting function and its coding sequence
06/04/2003CN1421245A Recombinant human interleukin-11 prepn for injection and its prepn process
06/04/2003CN1110559C Gene for regulating aureobasidin sensitivity
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110557C LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idio type antibody
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110318C Antithrombosis medicine using inactive insuline as skeleton and containing arginine-glycine-aspartic acid sequence
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573240 Controlling lepidopteran insect pests by contacting with effective amount of toxin comprising insecticidal fragment of specified amino acid sequence
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573086 Transformed/transfected Chrysosporium lucknowense expressing/ secreting heterologous polypeptides; signal sequences; regula -tory sequences; mutants; Trichoderma reesei; use in making large amounts of protein/polypeptide in a low cost manner
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573074 Methods for ansamitocin production
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003US6573070 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6573065 Thermostable proteolytic enzymes and uses thereof in peptide protein synthesis
06/03/2003US6573055 Immunoglobulin for use in the detection of preferential proteins in bodily fuids of mammals
06/03/2003US6572857 Psoriasis; humanized sub clone of IOR T1A produced by the hybridoma deposited with ECACC, CAMR under accession number 96112640, having heavy and light chains with humanized variable regions.
06/03/2003US6572853 Recombinant human beta interferon with enhanced solubility
06/03/2003US6572852 Genetic engineering
06/03/2003CA2217633C Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
06/03/2003CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use
06/03/2003CA2076424C Phosphoinositol-glycan-peptide with insulin-like action
05/2003
05/30/2003WO2003044214A2 Methods and compositions in checkpoint signaling
05/30/2003WO2003044210A2 Process for preparing insulin compounds
05/30/2003WO2003044192A1 Process for producing l-amino acid using escherichia
05/30/2003WO2003044189A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same
05/30/2003WO2003044187A2 Emulsion compositions
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044055A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
05/30/2003WO2003044054A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
05/30/2003WO2003044051A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003WO2003044049A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003WO2003044048A2 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003WO2003044043A1 Method of protein purification
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043566A2 Hip1 cancer markers
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor
05/30/2003WO2002074952A3 Nucleic acid which is stabilised against decomposition
05/30/2003WO2002074929A3 Evolving new molecular function
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003WO2002033065A3 Method for producing proteins by electroporation
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 1125